LA JOLLA, CA—Illnesses from Ebola virus and its relatives have about a 50 percent fatality rate in humans. The current outbreak in the Democratic Republic of Congo has already caused over 10,500 confirmed cases and over 5,130 deaths, according to the U.S. Centers for Disease Control and Prevention .
Ebola virus is a devastating pathogen. Like humans, bats can get infected with Ebola virus. So why don't bats get sick?
"Another puzzle," says lead author LJI Professor, President & CEO Erica Ollmann Saphire, Ph.D., MBA. "is why humans do get so sick. And why the worst cases can have the strongest inflammatory responses. These are strong immune responses, but they're not working well."
In a new Cell study , La Jolla Institute for Immunology (LJI) researchers, working in collaboration with Princeton University Professors Aartjan te Velthuis, Ph.D., and Clifford Brangwynne, Ph.D., and UC San Diego Professor Gene Yeo, Ph.D., MBA, share a key reason why humans are especially vulnerable to severe Ebola disease.
It may come down to viral "nests." Ebola virus builds protected, bubble-like "nests" inside host cells, technically termed membraneless condensates. The virus harbors its own viral mRNA inside these compartments.
What the researchers found, using a technique called spatial transcriptomics, is that Ebola virus also traps human cellular mRNA molecules inside these nests. When Ebola virus traps certain human mRNAs, the human immune system loses its ability to control dangerous inflammation. Fevers spike, organs fail, and Ebola disease turns deadly.
These mRNA molecules look different in bat cells, and they don't end up trapped by Ebola virus. As a result, bats keep Ebola virus infection in check and never show symptoms.
Ebola virus builds a 'nest'
When Ebola virus enters a host cell—be it human or bat—the virus constructs bubble-like structures called viral condensates (also known as viral factories). To produce progeny, the viral material physically condenses and separates from surrounding cellular content, creating a distinct compartment where viral building blocks are enriched.
"When birds land in a new place, they make nests where they can raise their babies. You can imagine viral condensates as nests for a virus," says Jingru Fang, Ph.D., who led this research as a member of the Saphire Lab at LJI. Saphire and Fang continued the work while Fang was a postdoctoral researcher at Princeton University.
As Ebola virus constructs its nest, it pulls in nearby molecules from the host cell. These molecules are called cellular mRNAs.
How the body is supposed to fight back
Your cells can't do anything without mRNAs. These little strands of molecules carry instructions from your genes (the "m" in mRNA stands for "messenger"). mRNAs shuttle genetic information from your cell nucleus to a structure called a ribosome. Ribosomes are cellular machines that translate the information encoded in mRNA sequences to build proteins. One copy of mRNA can serve as the blueprint for many copies of proteins.
In a healthy cell, mRNAs are meant to do their jobs and then degrade. Message sent, time to go.
That timely mRNA degradation is critical for our health, especially for a group of mRNAs encoding defense molecules that help us fight infections. Here's why:
Early in viral infection, those cells that are infected can secrete a molecule, called interferon (IFN), to alert nearby cells of an upcoming infection. This "danger" signal then triggers the expression of a panel of defense genes called Interferon Stimulated Genes or ISGs. The mRNAs of these genes can turn the whole cell into a battlefield against viral invasion—sometimes at the expense of shutting down normal cellular functions.
"This is a first line of defense that our bodies can mount," says Fang. "However, as you can imagine, if this aggressive response is kept up too long, it will cause damage to the host."
The same antiviral defense that kills viruses also harms healthy tissues, so cells are only supposed to turn ISG production "on" for short periods of time.
Thanks to mRNA degradation, cells can dial back antiviral response production before tissue damage takes over. "The antiviral response is like a weapon, and cells use degradation as a way to deactivate that weapon," says Fang.
This whole system falls apart when mRNAs get stuck in viral condensates.
What goes wrong in humans
Out-of-control cytokine production is what kills Ebola disease patients. "In patients with fatal cases, there tends to be this abnormal upregulation of a certain panel of genes that direct the innate immune response," says Fang.
The Saphire Lab specializes in structural biology—the molecular architecture of living things. For the new study, they took a close look at these condensates, and the structural differences between human and bat mRNAs trapped within them.
The researchers spotted small differences in the way human and bat mRNA molecules are folded inside cells. They found that human mRNA molecules with certain folded features tended to be recruited into viral condensates more often.
Importantly, many of the human mRNAs that got pulled into the condensates were the same mRNAs that normally direct the type I interferon (IFN) response, a rapid antiviral defense mechanism conserved in many cell types as part of the innate immunity. Expression of these powerful defense genes can only be induced by IFN, following rapid degradation to minimize damage.
Viral condensates shield these mRNAs from degradation. This means the mRNAs don't degrade properly, cytokine production stays "on," and inflammation overwhelms the body.
"These are potentially harmful kinds of genes," says Fang. "And now they're persisting longer than they normally would."
Bat mRNAs looked different. The scientists examined mRNAs from Egyptian fruit bats, a model fruit bat species and known reservoir species for the related Marburg virus (a relative of Ebola virus). Even though the bats expressed similar mRNAs as humans as part of the conserved antiviral defense, the bat defense mRNAs adopt a different folding feature from human mRNAs, and they were not recruited into viral condensates nearly as often.
As a result, says Fang, it appears that the bat immune system can control Ebola virus while keeping harmful inflammation at bay.
"We don't know whether this difference can explain everything, but it gives researchers a place to start looking and confirm what we've found in additional human or animal samples," says Fang.
Publication details:
Additional authors of the study, " RNA folding drives species-dependent host mRNA partitioning in Ebola virus condensates ," include Dylan C. Lam, Clarence K. Mah, Reika Watanabe, Hailey M. Tanner, Troy Comi, Yuan Cai, Cheng-Yi Chen, Aartjan J. W. te Velthuis, Clifford P. Brangwynne, and Gene W. Yeo.
This research received additional support from the Howard Hughes Medical Institute, the Princeton Biomolecular Condensate Program, the Princeton Center for Complex Materials, the U.S. National Science Foundation Materials Research Science and Engineering Centers (NSF DMR-2011750), the St. Jude Collaborative on Membraneless Organelles, the AFOSR Multidisciplinary Research Program of the University Research Initiative (FA9550-20-1-0241), the Chan Zuckerberg Initiative Exploratory Cell Network, the National Institutes of Health (grant DP2 AI17547401), and the UC San Diego Sanford Stem Cell Institute.
Fang was also supported by The Tullie and Rickey Families SPARK Awards for Innovations in Immunology , through the generosity of LJI Board Director Sandor Shapery and Rebecca Shapery, and a 2025 Omenn Darling Postdoctoral Fellowship through Princeton Bioengineering Institute.